The Time for Cytokine Therapeutics Is Now
We believe that cytokine therapeutics engineered to be selective and overcome their pleiotropy can fundamentally change the treatment paradigms of cancer and autoimmune, inflammatory, and metabolic diseases.
The Pipeline to Advance Our Mission
Using our team’s cumulative expertise and our proprietary cytokine technologies, we are developing a pipeline of selective immunotherapies against a wide range of important targets for the treatment of cancers and autoimmune, inflammatory, and metabolic diseases.